Privately held HemoSense Inc. of Milpitas, California, said on Tuesday that it received clearance from the US Food and Drug Administration (FDA) to market its INRatio for in-home use by patients on oral anticoagulant therapy.
INRatio is a portable, handheld analyzer designed to test and record the clotting time of blood using a prothrombin time (PT) analysis. The product consists of a meter and disposable test strips to be used by the patient at home, or by medical professionals in an office or clinical setting.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!